Prenatal And Newborn Genetic Testing Global Market Report 2025
상품코드:1825521
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
출생전·신생아 유전자 검사 시장 규모는 향후 수년간 급성장이 전망됩니다. 2029년에는 CAGR 12.3%로 120억 7,000만 달러로 성장합니다. 예측 기간의 성장은 유전자 검사 패널의 확대, 임산부의 건강 인식 증가, 산전/신생아 검진 가이드라인, 희귀질환에 대한 관심 증가, 윤리적/규제적 고려사항 등에 기인하는 것으로 보입니다. 예측 기간의 주요 동향으로는 비침습적 산전검사(NIPT), 유전체 시퀀싱(WGS) 및 전체 엑솜 시퀀싱, 인공지능(AI) 통합, 착상 전 유전학적 검사(PGT), 소비자 직접 유전자 검사 등이 있습니다.
향후 5년간 12.3%의 성장률 전망은 지난번 예측보다 0.1% 소폭 하락한 수치입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향에 기인합니다. 관세 장벽은 한국과 스위스에서 공급되는 비침습적 산전검사(NIPT) 키트와 신생아 선별 시약의 비용을 상승시킴으로써 중요한 조기 진단을 지연시키고, 산모와 태아의 의료비를 상승시킴으로써 미국을 저해할 것으로 예측됩니다. 또한 상호 관세와 무역 긴장과 제한 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향은 더욱 광범위하게 나타날 것으로 보입니다.
산전검사 및 신생아 유전자 검사에 대한 정부의 구상과 지원은 당분간 산전-신생아 유전자 검사 시장의 확대를 촉진할 것으로 예측됩니다. 이러한 노력에는 특정 문제를 해결하거나 시민의 행복을 증진하기 위해 다양한 수준의 정부 기관이 도입하는 특정 행동, 프로그램, 정책 등이 포함됩니다. 정부는 산전-신생아 유전자 검사 프로그램을 옹호하고 지원함으로써 임신 중이나 출생 직후 태아의 유전자 이상이나 상태를 파악하는 데 기여하고 있습니다. 2022년 6월, 호주 정부가 뉴사우스웨일스주(NSW)의 신생아 검진 프로그램에 매년 130만 달러를 지원한 것이 그 예입니다. 이 기금은 중증복합면역결핍증(SCID)과 척수성 근위축증(SMA)에 대한 무료 검사를 촉진하고, 주내 모든 신생아에게 유전자 검사를 제공하여 연간 10만 명의 신생아 중 13명의 생명을 구할 수 있는 기회를 제공할 수 있습니다. 따라서 산전 및 신생아 유전자 검사를 강화하려는 정부의 구상이 각 검사 시장의 성장을 촉진하고 있습니다.
목차
제1장 개요
제2장 시장의 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세 및 Covid와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 출생전·신생아 유전자 검사 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 용도 산업의 분석
세계의 출생전·신생아 유전자 검사 시장 : 성장률 분석
세계의 출생전·신생아 유전자 검사 시장 실적 : 규모와 성장, 2019-2024
세계의 출생전·신생아 유전자 검사 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계의 출생전·신생아 유전자 검사 : TAM(Total Addressable Market)
제6장 시장 세분화
세계의 출생전·신생아 유전자 검사 시장 : 제품 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
소모품
기기
세계의 출생전·신생아 유전자 검사 시장 : 스크리닝별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
비침습적 출생전 검사
만성 융모 채취
양수천자
모체혈청 스크리닝
기타 스크리닝
세계의 출생전·신생아 유전자 검사 시장 : 질환별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
다운 증후군
페닐케톤뇨증
낭포성 섬유증
겸상 적혈구 빈혈
세계의 출생전·신생아 유전자 검사 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
병원
산과·전문 클리닉
진단 센터
세계의 출생전·신생아 유전자 검사 시장 : 서브 세분화 소모품(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
시약과 어세이
샘플 채취 키트
검사 키트
세계의 출생전·신생아 유전자 검사 시장 : 서브 세분화 기기(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
중합효소 연쇄 반응(PCR) 기계
시퀸서
마이크로어레이 애널라이저
제7장 지역별·국가별 분석
세계의 출생전·신생아 유전자 검사 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 출생전·신생아 유전자 검사 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
출생전·신생아 유전자 검사 시장 : 경쟁 구도
출생전·신생아 유전자 검사 시장 : 기업 개요
F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
Novartis AG Overview, Products and Services, Strategy and Financial Analysis
Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 대기업과 혁신적 기업
Danaher Corporation
Siemens Healthineers AG
Becton, Dickinson and Company
Quest Diagnostic Incorporated
Agilent Technologies Inc.
Grifols S.A.
Terumo Corporation
Illumina Inc.
PerkinElmer Genomics
Quidel Corporation
Bio-Rad Laboratories Inc.
Qiagen NV
Werfen S.A.
DiaSorin S.p.A
Nova Biomedical
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 합병과 인수
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
출생전·신생아 유전자 검사 시장 2029 : 새로운 기회를 제공하는 국가
출생전·신생아 유전자 검사 시장 2029 : 새로운 기회를 제공하는 부문
출생전·신생아 유전자 검사 시장 2029 : 성장 전략
시장 동향에 기반한 전략
경쟁사 전략
제36장 부록
KSA
영문 목차
영문목차
Prenatal and newborn genetic testing encompasses medical procedures and screenings conducted during pregnancy and after birth to assess the genetic health and risk factors of both the developing fetus and the newborn baby. These tests are crucial for detecting and identifying genetic disorders, congenital conditions, or hereditary diseases that may impact the child's health or development.
The primary product types within the prenatal and newborn genetic testing domain include consumables and instruments. Instruments refer to specialized tools or devices designed for specific tasks or measurements, including various genetic analyzers used by healthcare professionals to conduct screenings and tests. Various screening methods include non-invasive prenatal testing, chronic villus sampling, amniocentesis, maternal serum screening, and others. The tests aim to identify diseases such as Down syndrome, phenylketonuria, cystic fibrosis, and sickle cell anemia. These genetic testing products find application across diverse end-users, including hospitals, maternity and specialty clinics, and diagnostic centers.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The prenatal and newborn genetic testing market research report is one of a series of new reports from The Business Research Company that provides prenatal and newborn genetic testing market statistics, including prenatal and newborn genetic testing industry global market size, regional shares, competitors with a prenatal and newborn genetic testing market share, detailed prenatal and newborn genetic testing market segments, market trends and opportunities, and any further data you may need to thrive in the prenatal and newborn genetic testing industry. This prenatal and newborn genetic testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The prenatal and newborn genetic testing market size has grown rapidly in recent years. It will grow from $6.68 billion in 2024 to $7.6 billion in 2025 at a compound annual growth rate (CAGR) of 13.7%. The growth in the historic period can be attributed to improved non-invasive prenatal testing, increased maternal age, government support and healthcare policies, patient demand for early detection.
The prenatal and newborn genetic testing market size is expected to see rapid growth in the next few years. It will grow to $12.07 billion in 2029 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be attributed to expanded genetic test panels, increasing maternal health awareness, prenatal and newborn screening guidelines, rising focus on rare diseases, ethical and regulatory considerations. Major trends in the forecast period include non-invasive prenatal testing (NIPT), genome sequencing (WGS) and whole exome sequencing, integration of artificial intelligence (AI), preimplantation genetic testing (PGT), direct-to-consumer genetic testing.
The forecast of 12.3% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. by increasing the cost of non-invasive prenatal testing (NIPT) kits and newborn screening reagents sourced from South Korea and Switzerland, thereby delaying critical early diagnoses and elevating maternal-fetal medicine expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
Government initiatives and backing for prenatal testing and newborn genetic screening are anticipated to propel the expansion of the prenatal and newborn genetic testing markets in the foreseeable future. Such initiatives encompass specific actions, programs, or policies introduced by governmental bodies at various levels to address particular issues or promote the well-being of citizens. By advocating for and supporting prenatal and newborn genetic testing programs, governments contribute to the identification of genetic abnormalities or conditions in fetuses during pregnancy or shortly after birth. An illustration of this is seen in the Australian government's allocation of $1.3 million annually to the New South Wales (NSW) newborn screening program in June 2022. This funding facilitated free testing for severe combined immunodeficiency (SCID) and spinal muscular atrophy (SMA), providing genetic screening to all newborns in the state and potentially saving the lives of 13 infants with these genetic disorders among the 100,000 babies born yearly. Hence, government initiatives fortifying prenatal and newborn genetic screening drive the growth of the respective testing markets.
The rising incidence of genetic disorders is anticipated to drive growth in the prenatal and newborn genetic testing market in the future. Genetic disorders are medical conditions caused by abnormalities or mutations in an individual's DNA or genetic material. Prenatal and newborn genetic testing enables the early identification of these disorders, often before symptoms appear, allowing healthcare providers to implement timely interventions and treatment strategies. For example, in May 2024, the Centers for Disease Control and Prevention (CDC), a US-based public health agency, reported that sickle cell disease (SCD) affects approximately 100,000 individuals in the United States. Among those affected, over 90% are non-Hispanic Black or African American, while an estimated 3%-9% are Hispanic or Latino. Thus, the increasing prevalence of genetic disorders is propelling the growth of the prenatal and newborn genetic testing market.
Leading companies in the prenatal and newborn genetic testing sectors are concentrating on developing innovative screening tests, particularly noninvasive prenatal screening tests, to enhance accessibility and affordability while ensuring dependable services for customers. Noninvasive prenatal screening (NIPS) or noninvasive prenatal testing (NIPT) represents an advanced and secure genetic screening method conducted during pregnancy to evaluate the risk of specific fetal chromosomal abnormalities. An instance of this advancement is Juno Diagnostics Inc.'s introduction of Juno Hazel in November 2022. This noninvasive prenatal screening test identifies chromosomal anomalies and offers clinical content using a sample collection kit, eliminating the necessity for phlebotomy and enhancing accessibility. Additionally, the company intends to provide educational resources and personalized genetic counseling support by partnering with healthcare professionals and genetic counselors.
In February 2024, CooperSurgical Inc., a US-based medical equipment manufacturing company, formed a partnership with Fulgent Genetics to enhance its offerings in the prenatal and newborn genetic testing market. This collaboration aims to leverage Fulgent Genetics' expertise in advanced genetic testing solutions, particularly for families using the Cord Blood Registry. Fulgent Genetics Inc. specializes in providing a range of prenatal and newborn genetic testing services, which aligns with CooperSurgical's goals of expanding its portfolio and improving access to critical genetic testing options for expectant families.
Major companies operating in the prenatal and newborn genetic testing market report are F. Hoffmann-La Roche AG, Novartis AG, Sanofi S.A., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton, Dickinson and Company, Quest Diagnostic Incorporated, Agilent Technologies Inc., Grifols S.A., Terumo Corporation, Illumina Inc., PerkinElmer Genomics, Quidel Corporation, Bio-Rad Laboratories Inc., Qiagen NV, Werfen S.A., DiaSorin S.p.A, Nova Biomedical, BGI Group, Natera Inc., Trinity Biotech PLC, Meridian Bioscience Inc., Sekisui Diagnostics, Chembio Diagnostics, PTS Diagnostics, Ariosa Diagnostics Inc., AccuBioTech Co. Ltd., Sequenom Inc.
North America was the largest region in the prenatal and newborn genetic testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the prenatal and newborn genetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the prenatal and newborn genetic testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The prenatal and newborn genetic testing market consists of revenues earned by entities by providing services such as prenatal screening tests, prenatal diagnostic tests, carrier screening for genetic conditions, and newborn screening tests. The market value includes the value of related goods sold by the service provider or included within the service offering. The prenatal and newborn genetic testing market also includes sales of electrophoresis equipment, genetic sequencing machines, and microarray analysis instruments. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Prenatal And Newborn Genetic Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on prenatal and newborn genetic testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for prenatal and newborn genetic testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The prenatal and newborn genetic testing market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Product Type: Consumables; Instruments
2) By Screening: Non-Invasive Prenatal Testing; Chronic Villus Sampling; Amniocentesis; Maternal Serum Screening; Other Screenings
3) By Disease: Down Syndrome; Phenylketonuria; Cystic Fibrosis; Sickle Cell Anemia
4) By End User: Hospital; Maternity And Specialty Clinics; Diagnostic Centers
Subsegments:
1) By Consumables: Reagents And Assays; Sample Collection Kits; Test Kits
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Prenatal And Newborn Genetic Testing Market Characteristics
3. Prenatal And Newborn Genetic Testing Market Trends And Strategies
4. Prenatal And Newborn Genetic Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Prenatal And Newborn Genetic Testing Growth Analysis And Strategic Analysis Framework
5.1. Global Prenatal And Newborn Genetic Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Prenatal And Newborn Genetic Testing Market Growth Rate Analysis
5.4. Global Prenatal And Newborn Genetic Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Prenatal And Newborn Genetic Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Prenatal And Newborn Genetic Testing Total Addressable Market (TAM)
6. Prenatal And Newborn Genetic Testing Market Segmentation
6.1. Global Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Consumables
Instruments
6.2. Global Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Non-Invasive Prenatal Testing
Chronic Villus Sampling
Amniocentesis
Maternal Serum Screening
Other Screenings
6.3. Global Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Down Syndrome
Phenylketonuria
Cystic Fibrosis
Sickle Cell Anemia
6.4. Global Prenatal And Newborn Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital
Maternity And Specialty Clinics
Diagnostic Centers
6.5. Global Prenatal And Newborn Genetic Testing Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Reagents And Assays
Sample Collection Kits
Test Kits
6.6. Global Prenatal And Newborn Genetic Testing Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Polymerase Chain Reaction (PCR) Machines
Sequencers
Microarray Analyzers
7. Prenatal And Newborn Genetic Testing Market Regional And Country Analysis
7.1. Global Prenatal And Newborn Genetic Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Prenatal And Newborn Genetic Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Prenatal And Newborn Genetic Testing Market
8.1. Asia-Pacific Prenatal And Newborn Genetic Testing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Prenatal And Newborn Genetic Testing Market
9.1. China Prenatal And Newborn Genetic Testing Market Overview
9.2. China Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Prenatal And Newborn Genetic Testing Market
10.1. India Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Prenatal And Newborn Genetic Testing Market
11.1. Japan Prenatal And Newborn Genetic Testing Market Overview
11.2. Japan Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Prenatal And Newborn Genetic Testing Market
12.1. Australia Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Prenatal And Newborn Genetic Testing Market
13.1. Indonesia Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Prenatal And Newborn Genetic Testing Market
14.1. South Korea Prenatal And Newborn Genetic Testing Market Overview
14.2. South Korea Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Prenatal And Newborn Genetic Testing Market
15.1. Western Europe Prenatal And Newborn Genetic Testing Market Overview
15.2. Western Europe Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Prenatal And Newborn Genetic Testing Market
16.1. UK Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Prenatal And Newborn Genetic Testing Market
17.1. Germany Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Prenatal And Newborn Genetic Testing Market
18.1. France Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Prenatal And Newborn Genetic Testing Market
19.1. Italy Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Prenatal And Newborn Genetic Testing Market
20.1. Spain Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Prenatal And Newborn Genetic Testing Market
21.1. Eastern Europe Prenatal And Newborn Genetic Testing Market Overview
21.2. Eastern Europe Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Prenatal And Newborn Genetic Testing Market
22.1. Russia Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Prenatal And Newborn Genetic Testing Market
23.1. North America Prenatal And Newborn Genetic Testing Market Overview
23.2. North America Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Prenatal And Newborn Genetic Testing Market
24.1. USA Prenatal And Newborn Genetic Testing Market Overview
24.2. USA Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Prenatal And Newborn Genetic Testing Market
25.1. Canada Prenatal And Newborn Genetic Testing Market Overview
25.2. Canada Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Prenatal And Newborn Genetic Testing Market
26.1. South America Prenatal And Newborn Genetic Testing Market Overview
26.2. South America Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Prenatal And Newborn Genetic Testing Market
27.1. Brazil Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Prenatal And Newborn Genetic Testing Market
28.1. Middle East Prenatal And Newborn Genetic Testing Market Overview
28.2. Middle East Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Prenatal And Newborn Genetic Testing Market
29.1. Africa Prenatal And Newborn Genetic Testing Market Overview
29.2. Africa Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Prenatal And Newborn Genetic Testing Market Competitive Landscape And Company Profiles
30.1. Prenatal And Newborn Genetic Testing Market Competitive Landscape
30.2. Prenatal And Newborn Genetic Testing Market Company Profiles
30.2.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
31. Prenatal And Newborn Genetic Testing Market Other Major And Innovative Companies
31.1. Danaher Corporation
31.2. Siemens Healthineers AG
31.3. Becton, Dickinson and Company
31.4. Quest Diagnostic Incorporated
31.5. Agilent Technologies Inc.
31.6. Grifols S.A.
31.7. Terumo Corporation
31.8. Illumina Inc.
31.9. PerkinElmer Genomics
31.10. Quidel Corporation
31.11. Bio-Rad Laboratories Inc.
31.12. Qiagen NV
31.13. Werfen S.A.
31.14. DiaSorin S.p.A
31.15. Nova Biomedical
32. Global Prenatal And Newborn Genetic Testing Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Prenatal And Newborn Genetic Testing Market
34. Recent Developments In The Prenatal And Newborn Genetic Testing Market
35. Prenatal And Newborn Genetic Testing Market High Potential Countries, Segments and Strategies
35.1 Prenatal And Newborn Genetic Testing Market In 2029 - Countries Offering Most New Opportunities
35.2 Prenatal And Newborn Genetic Testing Market In 2029 - Segments Offering Most New Opportunities
35.3 Prenatal And Newborn Genetic Testing Market In 2029 - Growth Strategies
